PMID- 25228542 OWN - NLM STAT- MEDLINE DCOM- 20141222 LR - 20211021 IS - 1552-5783 (Electronic) IS - 0146-0404 (Print) IS - 0146-0404 (Linking) VI - 55 IP - 10 DP - 2014 Sep 16 TI - Nerve fiber layer thinning lags retinal ganglion cell density following crush axonopathy. PG - 6505-13 LID - 10.1167/iovs.14-14525 [doi] AB - PURPOSE: We investigated the progressive nature of neurodegenerative structural changes following injury to retinal ganglion cell (RGC) axons using quantifiable and noninvasive in vivo imaging techniques. METHODS: To track degenerative RGC progression in retinas following optic nerve crush (ONC) injury, spectral-domain optical coherence tomography (SD-OCT) was used to quantitate the RGC nerve fiber layer (NFL) density. The RGC soma cell density (RCD) was measured by confocal scanning laser ophthalmoscopy (CSLO). The RCD counts were performed using blood vessels as landmarks to anatomically track defined progressive changes in enhanced yellow fluorescent fusion protein (EYFP)-labeled RGCs. RESULTS: Following ONC injury, 68% of the observed decrease in RCD measured by CSLO and 54% of the NFL thickness obtained by SD-OCT imaging (N=4 retinas) occurred within the first week. Between days 7 and 14, an additional 22% decrease in RCD was concurrent with a 31% decrease in overall NFL thickness. Finally, between days 14 and 21, an additional 10% decrease in RCD measured in vivo by CSLO and 15% decrease in NFL thickness by SD-OCT was observed. CONCLUSIONS: Our data suggest that in vivo CSLO imaging of EYFP-RGC expression and SD-OCT measured NFL thickness are fast and reliable methods that longitudinally track neurodegenerative progression following ONC injury. Neurodegenerative changes in NFL thickness measured by SD-OCT imaging have the same overall trajectory as those observed by CSLO for RCD; however, changes in NFL thickness initially lag behind in vivo RGC soma counts with a slower decline in overall measurable change. CI - Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc. FAU - Munguba, Gustavo C AU - Munguba GC AD - Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States. FAU - Galeb, Sanja AU - Galeb S AD - Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States. FAU - Liu, Yuan AU - Liu Y AD - Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States. FAU - Landy, David C AU - Landy DC AD - Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States. FAU - Lam, Daisy AU - Lam D AD - Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States. FAU - Camp, Andrew AU - Camp A AD - Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States. FAU - Samad, Sinthia AU - Samad S AD - Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States. FAU - Tapia, Mary L AU - Tapia ML AD - Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States. FAU - Lee, Richard K AU - Lee RK AD - Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States. LA - eng GR - P30 EY014801/EY/NEI NIH HHS/United States GR - EY014801/EY/NEI NIH HHS/United States GR - F31 EY022872/EY/NEI NIH HHS/United States GR - EY016775/EY/NEI NIH HHS/United States GR - EY022872/EY/NEI NIH HHS/United States GR - K08 EY016775/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20140916 PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 SB - IM MH - Animals MH - Axons/*pathology MH - Cell Count MH - Disease Models, Animal MH - Mice MH - Mice, Transgenic MH - Nerve Crush/adverse effects MH - Optic Disk/*pathology MH - Optic Nerve Injuries/*pathology MH - Retinal Ganglion Cells/*pathology MH - Tomography, Optical Coherence PMC - PMC4201323 OTO - NOTNLM OT - glaucoma OT - neurodegeneration OT - optical coherence tomography OT - retinal ganglion cells OT - scanning laser ophthalmoscopy EDAT- 2014/09/18 06:00 MHDA- 2014/12/23 06:00 PMCR- 2015/04/01 CRDT- 2014/09/18 06:00 PHST- 2014/09/18 06:00 [entrez] PHST- 2014/09/18 06:00 [pubmed] PHST- 2014/12/23 06:00 [medline] PHST- 2015/04/01 00:00 [pmc-release] AID - iovs.14-14525 [pii] AID - 10.1167/iovs.14-14525 [doi] PST - epublish SO - Invest Ophthalmol Vis Sci. 2014 Sep 16;55(10):6505-13. doi: 10.1167/iovs.14-14525.